Ruth Berry

Ruth Berry is the Director of Analytical Strategy at GentiBio. Prior to joining GentiBio, Ruth was the Associate Director of Analytical Strategy at Juno Therapeutics, building a team that supported early and mid-phase cell therapy products. Ruth held multiple roles at Juno Therapeutics, including CMC Lead and Analytical Lead for multiple early-stage cell therapy programs, Molecular Assay team lead, and method developer. Prior to joining the cell therapy community, Ruth taught Biology and Microbiology at Umpqua Community College. Ruth holds a BA in Biology from Grinnell College and a Ph.D. in Cellular and Molecular Biology from Northwestern University.